Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies, including gene elimination, gene ...

Explore how artificial intelligence AI revolutionizes genomics by enhancing gene editing decoding human DNA and advancing precision medicine Learn more about its transformative impact on the website G ...

Results prove that inversions can be generated in plants without causing further unwanted changes in the expression of genetic information.

"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.A novel ...

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...